RESUMO
The effect of immunization with Burkholderia pseudomallei, (Pur- and Ts), heterologous vaccines and the recombinant culture of Francisella tularensis RM2, carrying a plasmid with fragments of B. pseudomallei chromosome, was studied on four species of experimental animals, essentially differing by their sensitivity to melioidosis. B. pseudomallei mutants formed the statistically significant level of protection in subcutaneously challenged animals, moderately sensitive to melioidosis, but were not effective when tested, under the same conditions, in animals, highly sensitive to melioidosis. The effect produced by the experimental vaccines under study in animals of all species, subjected to aerogenic challenge, was leveled. The study showed good prospects for the use of tularemia vaccine with a view to create heterologous immunity to melioidosis and the possibility of its use as the basis of bivalent gene engineering vaccine.
Assuntos
Vacinas Bacterianas/imunologia , Burkholderia pseudomallei/imunologia , Melioidose/prevenção & controle , Vacinas Sintéticas/imunologia , Animais , Vacinas Bacterianas/toxicidade , Burkholderia pseudomallei/genética , Burkholderia pseudomallei/patogenicidade , Cromossomos Bacterianos/genética , Avaliação Pré-Clínica de Medicamentos , Francisella tularensis/genética , Francisella tularensis/imunologia , Cobaias , Imunização , Camundongos , Mutação , Plasmídeos/genética , Ratos , Vacinas Atenuadas/imunologia , Vacinas Atenuadas/toxicidade , Vacinas Combinadas/imunologia , Vacinas Combinadas/toxicidade , Vacinas Sintéticas/toxicidade , VirulênciaRESUMO
The toxicity, immunogenic properties and protective activity of the live culture of E. coli M17 and antigenic preparations obtained from cell suspensions of this strain have been studied under experimental conditions. As revealed in experiments on mice, E. coli M17 live culture has low virulence, moderate toxicity and provides the protection of immunized mice from challenge with homologous and highly virulent E. coli strains. E. coli M17 live culture, when introduced orally or intravenously into rabbits, ensures the synthesis of 02 and H6 antibodies. Blood sera taken from immunized rabbits yield better results than initial sera in experiments on the passive protection of mice. The results of our experiments show the expediency of the clinical trials of Colibacterin as a perspective Escherichia live oral vaccine.
Assuntos
Vacinas Bacterianas/imunologia , Colicinas/imunologia , Escherichia coli/imunologia , Animais , Antígenos de Bactérias/imunologia , Antígenos de Bactérias/toxicidade , Vacinas Bacterianas/toxicidade , Colicinas/toxicidade , Relação Dose-Resposta Imunológica , Avaliação Pré-Clínica de Medicamentos , Escherichia coli/patogenicidade , Infecções por Escherichia coli/prevenção & controle , Imunização , Camundongos , Coelhos , Fatores de Tempo , Vacinas Atenuadas/imunologia , Vacinas Atenuadas/toxicidade , Virulência/imunologiaRESUMO
The immunogenic potency, toxicity, homologous and heterologous protective activity of lipopolysaccharide preparations obtained from serogroup A N. meningitidis (LPS A) were studied in animal experiments. These preparations were shown to possess very high protective activity. The alkaline treatment of native LPS A decreased the toxicity of the preparation almost 20 times and did not affect its immunogenic potency. Detoxified LPS A was capable of protecting mice from fatal meningococcemia resulting from infection with N. meningitidis strains, serogroups A, B and C; the adsorption of the preparation on aluminium hydroxide did not affect its protective activity. In view of the properties of detoxified LPS A revealed in this investigation, it may be regarded as a possible vaccinal preparation.
Assuntos
Vacinas Bacterianas/imunologia , Lipopolissacarídeos/imunologia , Neisseria meningitidis/imunologia , Vacinas Atenuadas/imunologia , Adsorção , Hidróxido de Alumínio , Animais , Vacinas Bacterianas/uso terapêutico , Vacinas Bacterianas/toxicidade , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Dose Letal Mediana , Lipopolissacarídeos/uso terapêutico , Lipopolissacarídeos/toxicidade , Infecções Meningocócicas/prevenção & controle , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Sepse/prevenção & controle , Vacinas Atenuadas/uso terapêutico , Vacinas Atenuadas/toxicidadeAssuntos
Produtos Biológicos/normas , Células Cultivadas/efeitos dos fármacos , Alternativas aos Testes com Animais , Animais , Vacinas Bacterianas/normas , Vacinas Bacterianas/toxicidade , Produtos Biológicos/toxicidade , Avaliação Pré-Clínica de Medicamentos/métodos , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Humanos , Soros Imunes/normas , Soros Imunes/toxicidade , Controle de Qualidade , Projetos de Pesquisa , Vacinas/normas , Vacinas/toxicidade , Vacinas Atenuadas/normas , Vacinas Atenuadas/toxicidade , Vacinas Virais/normas , Vacinas Virais/toxicidade , Organização Mundial da SaúdeRESUMO
Experiments in laboratory animals demonstrated safety, areactogenicity, and low allergenic potential of inactivated influenza chromatographic vaccine (IICV) administered by aerosol method. Aerosol immunization of white rats resulted in the development of the same level of secretory antibody as after intraperitoneal inoculation of IICV but the immunizing aspirational dose was 10-20 times as low as parenteral. Marked protection of mice was achieved after triple aerosol immunization of immunologically experienced animals.
Assuntos
Vacinas contra Influenza/toxicidade , Aerossóis , Anafilaxia/imunologia , Animais , Anticorpos Antivirais/análise , Relação Dose-Resposta Imunológica , Avaliação Pré-Clínica de Medicamentos , Cobaias , Imunização/métodos , Vírus da Influenza A/imunologia , Vacinas contra Influenza/administração & dosagem , Vacinas contra Influenza/imunologia , Injeções Intramusculares , Camundongos , Ratos , Fatores de Tempo , Vacinas Atenuadas/administração & dosagem , Vacinas Atenuadas/imunologia , Vacinas Atenuadas/toxicidadeRESUMO
Biological properties of influenza vaccines were studied on experimental animals inoculated intraperitoneally with regard to the vaccine effect on peritoneal exudate cells. The development of neutrophilia and inhibition of acid phosphatase activity in macrophages within the first 24 hours after intraperitoneal inoculation of influenza viruses or influenza vaccines were used for determination of the toxic effect of the inoculum. The values of subsequent later activation of acid phosphatase in macrophages allowed the immunogenic properties of the vaccines under study to be evaluated. The sensitizing properties of the virus antigens were assessed by the reaction of the lymphoid-macrophage system after multiple inoculations of the preparations. A correlation of changes observed in the experimental animals with reactogenicity and values of immunity against influenza in man and animals was established.